Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7236 results

Sort By:

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

Study ID: NCT03568292
Start Date: 2022-03-01
End Date: 2027-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Best Practice

Laboratory Biomarker Analysis

Oculus Rift Headset

Administration questionnaire

Sponsor

University of Southern California

Source: clinicaltrials.gov

Share:
Add to list

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

Study ID: NCT01555892
Start Date: 2013-01-14
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

136

Intervention / Treatment

EBV-specific T cells: A

EBV-specific T cells: B

Sponsor

Baylor College of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Patient Priorities for Survivorship Care in Older Breast Cancer Survivors

Study ID: NCT06478589
Start Date: 2025-01-02
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Adapted Patient Priorities Care (PPC) approach

Usual Care

Sponsor

The University of Texas Health Science Center, Houston

Source: clinicaltrials.gov

Share:
Add to list

Study of Selinexor in Combination with Ruxolitinib in Myelofibrosis

Study ID: NCT04562389
Start Date: 2021-03-11
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

350

Intervention / Treatment

Selinexor

Selinexor

Placebo

Rheops

Sponsor

Karyopharm Therapeutics Inc

Source: clinicaltrials.gov

Share:
Add to list

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Study ID: NCT00801489
Start Date: 2007-04-04
End Date: 2028-10-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

270

Intervention / Treatment

Cytarabine

Decitabine

Filgrastim-sndz

Fludarabine Phosphate

Gemtuzumab ozogamicin

Again

Laboratory Biomarker Analysis

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Study ID: NCT06475989
Start Date: 2024-08-22
End Date: 2030-09-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

264

Intervention / Treatment

Biospecimen Collection

Cabozantinib

Computed Tomography

Dabrafenib

Magnetic Resonance Imaging

Administration questionnaire

Trametinib

Sponsor

ECOG-ACRIN Cancer Research Group

Source: clinicaltrials.gov

Share:
Add to list

Proton Radiation Therapy Registry

Study ID: NCT04376229
Start Date: 2020-04-07
End Date: 2040-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

5000

Intervention / Treatment

Registry

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Study ID: NCT05142592
Start Date: 2021-11-15
End Date: 2025-12-21
Study Type

Interventional

Study Phase

Phase2

No. of Participants

196

Intervention / Treatment

IPG7236

Sponsor

Nanjing Immunophage Biotech Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

NTS-WBRT in Brain Metastases

Study ID: NCT05013892
Start Date: 2022-02-08
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

41

Intervention / Treatment

NTS-WBRT (normal tissue sparing whole brain radiation therapy)

Memantine

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

Study ID: NCT05828589
Start Date: 2023-06-20
End Date: 2027-04
Study Type

Interventional

Study Phase

Phase1

No. of Participants

112

Intervention / Treatment

BGB-21447

Sponsor

Beigene

Source: clinicaltrials.gov

Share:
Add to list